PRKCSH and lung carcinoma: The gain of IGF1R in PRKCSH-deficient cells increased caspase-8 phosphorylation and Mcl-1 expression levels, whereas IGF1R knockdown reduced caspase-8 phosphorylation and Mcl-1 expression levels in lung cancer cells.